Related Experiment Videos
Evaluating chronic venous disease with a new venous severity scoring system
Michael A Ricci1, Joseph Emmerich, Peter W Callas
1Department of Surgery, Vermont College of Medicine, Burlington, 05405-0068, USA. michael.ricci@uvm.edu
Journal of Vascular Surgery
|November 7, 2003
Summary
The Venous Clinical Severity Score (VCSS) effectively screens for venous disease, correlating well with ultrasound findings. A VCSS score of 0 indicates a high likelihood of no venous abnormalities.
Area of Science:
- Vascular Medicine
- Diagnostic Imaging
- Clinical Assessment
Background:
- The Venous Clinical Severity Score (VCSS) was developed to objectively assess venous disease severity.
- Existing clinical classifications like CEAP lack objective test validation.
- This study aimed to validate the VCSS against objective venous ultrasound (US) findings.
Purpose of the Study:
- To evaluate the correlation between the Venous Clinical Severity Score (VCSS) and venous ultrasound (US) scan abnormalities.
- To determine the VCSS's utility as a screening tool for venous disease.
Main Methods:
- VCSS and venous US scans were performed on 210 patients (420 limbs) from a protein C deficient kindred.
- A single examiner scored VCSS clinically, while another blinded examiner performed US.
- Statistical analysis included odds ratios (OR) and confidence intervals (CI) to assess the relationship between VCSS and US findings.
Main Results:
- A significant association was observed between VCSS scores and US-detected venous abnormalities.
- Limbs with a VCSS greater than 0 had a 26.5-fold increased likelihood of US abnormalities (OR, 26.5; 95% CI, 11-64).
- The VCSS demonstrated high sensitivity (89.3%) and specificity (76.1%) compared to ultrasonography.
Conclusions:
- The VCSS is a useful screening tool for identifying venous disease, particularly in high-risk populations.
- A VCSS score of 0 strongly suggests the absence of venous disease.
- The VCSS shows good correlation with objective US findings, supporting its clinical utility.